Immunoblotting

TR Teresa L. Ramos
LS Luis Ignacio Sánchez-Abarca
SM Sandra Muntión
SP Silvia Preciado
NP Noemí Puig
GL Guillermo López-Ruano
ÁH Ángel Hernández-Hernández
AR Alba Redondo
RO Rebeca Ortega
CR Concepción Rodríguez
FS Fermín Sánchez-Guijo
CC Consuelo del Cañizo
request Request a Protocol
ask Ask a question
Favorite

Ultracentrifuged EV were re-suspended in lysis buffer (25 mM HEPES, pH 7.5, 150 mM NaCl, 1%Igepal, 10 % glycerol, 10 mM MgCl2, 1 mM EDTA, 25 mM NaF, 1 mM Na2VO4, plus proteinase inhibitors), and incubated 20 min on ice. Non-soluble material was eliminated by centrifugation. Protein concentrations were determined using the Bradford assay. Samples were then subjected to SDS-PAGE and the proteins were transferred onto Polyvinylidene fluoride (PVDF) membranes from GE Healthcare (Barcelona, Spain), as previously described [51]. Non-specific binding was blocked with 5 % non-fat dry milk. Primary antibodies were rabbit α-CD63 and α-CD81 (Exo AB Antibody Kit – System Biosciences) and rabbit α-CD73 (ab124725, Abcam Inc.). Incubation with the primary antibodies at the appropriate dilution was performed overnight at 4 °C. As secondary antibody an anti-rabbit IgG horseradish peroxidase-conjugated from Amersham Biosciences was used. Incubation with the secondary antibody was performed at room temperature for 1 h. Blots were visualized using chemiluminescence using ECL-Plus reagent (Amersham Biosciences).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A